Compromising the 19S proteasome complex protects cells from reduced flux through the proteasome

Author:

Tsvetkov Peter1,Mendillo Marc L2,Zhao Jinghui3,Carette Jan E4,Merrill Parker H5,Cikes Domagoj6,Varadarajan Malini1,van Diemen Ferdy R7,Penninger Josef M6,Goldberg Alfred L3,Brummelkamp Thijn R7,Santagata Sandro189,Lindquist Susan12

Affiliation:

1. Whitehead Institute for Biomedical Research, Cambridge, United States

2. Department of Biology, Howard Hughes Medical Institute, Massachusetts Institute of Technology, Cambridge, United States

3. Department of Cell Biology, Harvard Medical School, Boston, United States

4. Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, United States

5. Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, United States

6. Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna, Austria

7. Department of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands

8. Department of Pathology, Brigham and Women's Hospital, Boston, United States

9. Department of Cancer Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States

Abstract

Proteasomes are central regulators of protein homeostasis in eukaryotes. Proteasome function is vulnerable to environmental insults, cellular protein imbalance and targeted pharmaceuticals. Yet, mechanisms that cells deploy to counteract inhibition of this central regulator are little understood. To find such mechanisms, we reduced flux through the proteasome to the point of toxicity with specific inhibitors and performed genome-wide screens for mutations that allowed cells to survive. Counter to expectation, reducing expression of individual subunits of the proteasome's 19S regulatory complex increased survival. Strong 19S reduction was cytotoxic but modest reduction protected cells from inhibitors. Protection was accompanied by an increased ratio of 20S to 26S proteasomes, preservation of protein degradation capacity and reduced proteotoxic stress. While compromise of 19S function can have a fitness cost under basal conditions, it provided a powerful survival advantage when proteasome function was impaired. This means of rebalancing proteostasis is conserved from yeast to humans.

Funder

EMBO

National Institutes of Health

The Medical Foundation

Publisher

eLife Sciences Publications, Ltd

Subject

General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3